-
Wall Street Reacts To Ulta's Q3 Beat, Makeup Headwinds Remain A Concern
2019 Dec 09, 1:26pm | 711Cosmetic retailer Ulta Beauty Inc (NASDAQ: ULTA) reported a third-quarter earnings beat Thursday, but sales missed estimates by $75 million. Cosmetic Industry Weakness Buy-side expectations have come way down on Ulta, leading the company to deliver a surprise earnings beat amid worsening macro...
-
Canopy Growth Analyst Says Constellation Brands Likely To Bid On Cannabis Company's Equity
2019 Dec 09, 12:56pm | 488Canopy Growth (NYSE: CGC) shares jumped Monday when the company announced the appointment of Constellation Brands (NYSE: STZ) CFO David Klein as the cannabis company's CEO. The Analyst Cantor Fitzgerald’s Pablo Zuanic reiterated a Neutral rating on Canopy Growth with a CA$18.90...
-
Sell-Side Remains Optimistic On Sage Therapeutics Despite Depression Drug Disappointment
2019 Dec 06, 3:00pm | 623Sage Therapeutics Inc (NASDAQ: SAGE) shares fell more than 60% Thursday following a negative readout for its lead asset in major depressive disorder. The Analysts Morgan Stanley analyst Matthew Harrison maintained an Overweight rating for Sage but lowered the price target from $217 to $125. (See...
-
Cloudera Delivers Beat And Raise, But Growth Remains Lower Than Industry Rates
2019 Dec 06, 11:39am | 257Cloudera Inc (NYSE: CLDR) delivered an all-round beat in the third quarter and raised guidance for the fourth quarter and full year. The company’s business seems stable, but there is limited visibility into growth accelerating toward industry growth rates, according to Raymond James. The...
-
Biogen's CTAD Presentation On Aducanumab Elicits Mixed Response
2019 Dec 05, 2:01pm | 594Biogen Inc's (NASDAQ: BIIB) presentation of aducanumab data at the Clinical Trials On Alzheimer's Disease Congress has drawn a mixed response. In late October, Biogen announced plans to revive its Alzheimer's program following a new analysis conducted by the company in consultation...
-
Street Is Bullish On Five Below After Q3 Sales Beat
2019 Dec 05, 1:00pm | 521Five Below Inc (NASDAQ: FIVE) shares are sharply higher after reporting a third-quarter sales beat on Wednesday. Five Below reported quarterly earnings of 17 cents per share, which met the analyst consensus estimate. The company reported quarterly sales of $377.4 million, which beat the analyst...
-
Analysts Furnish Portfolios With RH After Beat-And-Raise Quarter
2019 Dec 05, 11:01am | 764Restoration Hardware Holdings (NYSE: RH) surged Thursday after reporting its third consecutive bottom-line beat and raise. “To management’s credit, this is becoming a common theme, as earnings have surprised to the upside multiple times this year,” Raymond James analysts...
-
At Home Wrecked: Analysts Break Down Retailer's Disastrous Forecast
2019 Dec 05, 9:14am | 768At Home Group Inc (NYSE: HOME) beat top- and bottom-line third-quarter estimates but disappointed analysts with a guidance cut. The store has reduced pricing on Christmas and everyday merchandise as the holiday season rolls slowly. “We expect shares to be weak on the news, but believe...
-
Bank Of America On Orange Investor Day: Increase In Capital Expenditure To Fund Growth
2019 Dec 04, 1:00pm | 332Orange SA (NYSE: ORAN) this week published its 2025 Plan. The plan suggests the company is preparing to take on some short-term pain for long-term gains, according to Bank of America Merrill Lynch. The Analyst Frederic Boulan maintained a Buy rating on Orange, keeping the price target at 18 euros....
-
Analysts Offer Positive Prognosis For UnitedHealth After Investor Day
2019 Dec 04, 12:10pm | 638UnitedHealth Group Inc (NYSE: UNH) plummeted ahead of Tuesday’s investor day and failed to recover throughout the session. However, analysts walked away from the presentation more bullish on the stock. “The investor day reinforced our thesis that we believe EPS visibility is high for...
-
Marvell's Valuation Keeps Morgan Stanley At Bay, While NXP Impresses With Growth Drivers, Returns
2019 Dec 04, 11:09am | 634Infrastructure semiconductor solutions provider Marvell Technology Group Ltd. (NASDAQ: MRVL) reported in-line fiscal third-quarter earnings but guided the fourth quarter lower. The company also announced securing of all necessary regulatory approvals for the proposed sale of its wireless...
-
Sell-Side Still Optimistic On Zscaler After Q1 Earnings Results
2019 Dec 04, 10:46am | 528Analysts remained upbeat on cloud security company Zscaler Inc. (NASDAQ: ZS) after strong first-quarter results, even as investors appeared more skeptical sending the stock down, likely on mixed second-quarter guidance. Zscaler beat Street expectations on revenue, billings, and non-GAAP EPS in the...
-
These Analysts Like HealthEquity's Post-Q3 Story
2019 Dec 04, 9:28am | 765HealthEquity Inc (NASDAQ: HQY) outperformed third-quarter expectations with a 47-cent bottom-line more than double analyst forecasts. Revenue of $157.1 million also beat consensus estimates of $152.4 million, while EBITDA closed the quarter at $56 million against $43 million forecasts....
-
Analyst: Lululemon's Luxury-Like Positioning Can Stretch Company To A $40B Market Cap
2019 Dec 03, 4:15pm | 459Amid all the retail woes apparel companies are seeing, the narrative simply doesn't apply to Lululemon Athletica Inc. (NASDAQ: LULU). The retailer's shares are up nearly 81% year to date. The LULU Analyst Cowen analyst John Kernan reiterates an Outperform rating on the stock and raised his...
-
Analyst Updates 2020 GE Healthcare Projections Following Investor Day Event
2019 Dec 03, 11:55am | 441General Electric Company (NYSE: GE) held a GE Healthcare investor day event this week. One analyst in attendance said Tuesday that Healthcare should be a stable source of free cash flow for GE as it executes its turnaround strategy, but the GE bull case still hinges on Power. The Analyst Bank of...